Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Estelle R Simons

Showing results (121-130 of 156) with videos related to

Pageof 16
Sort By:
The Journal of Allergy and Clinical Immunology|November 13, 2007
American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxisLinda Cox, Thomas A E Platts-Mills, Ira Finegold, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 1, 2012
Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbationsRobert S Zeiger, Ashley Yegin, F Estelle R Simons, et al.
Plos One|June 23, 2010
Are plasma IL-10 levels a useful marker of human clinical tolerance in peanut allergy?Larisa C Lotoski, F Estelle R Simons, Rishma Chooniedass, et al.
The Journal of Allergy and Clinical Immunology|April 3, 2007
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthmaBradley E Chipps, Stanley J Szefler, F Estelle R Simons, et al.
International Archives of Allergy and Immunology|June 18, 2002
Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shockEdgar Bautista, F Estelle R Simons, Keith J Simons, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 10, 2006
Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and ImmunologyLeonard Bielory, Michael Blaiss, Stanley M Fineman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel ConsensusMatthew Greenhawt, Ruchi S Gupta, J Allen Meadows, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthmaTmirah Haselkorn, Robert S Zeiger, Bradley E Chipps, et al.
The New England Journal of Medicine|January 4, 2008
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxisPeter Vadas, Milton Gold, Boris Perelman, et al.
Plos One|October 17, 2012
Elevated antigen-driven IL-9 responses are prominent in peanut allergic humansJungang Xie, Larisa C Lotoski, Rishma Chooniedass, et al.
Pageof 16

Showing results (121-130 of 156) with videos related to

Sort By:
Pageof 16
The Journal of Allergy and Clinical Immunology|November 13, 2007
American Academy of Allergy, Asthma & Immunology/American College of Allergy, Asthma and Immunology Joint Task Force Report on omalizumab-associated anaphylaxisLinda Cox, Thomas A E Platts-Mills, Ira Finegold, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|February 1, 2012
Evaluation of the National Heart, Lung, and Blood Institute guidelines impairment domain for classifying asthma control and predicting asthma exacerbationsRobert S Zeiger, Ashley Yegin, F Estelle R Simons, et al.
Plos One|June 23, 2010
Are plasma IL-10 levels a useful marker of human clinical tolerance in peanut allergy?Larisa C Lotoski, F Estelle R Simons, Rishma Chooniedass, et al.
The Journal of Allergy and Clinical Immunology|April 3, 2007
Demographic and clinical characteristics of children and adolescents with severe or difficult-to-treat asthmaBradley E Chipps, Stanley J Szefler, F Estelle R Simons, et al.
International Archives of Allergy and Immunology|June 18, 2002
Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shockEdgar Bautista, F Estelle R Simons, Keith J Simons, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|May 10, 2006
Concerns about intranasal corticosteroids for over-the-counter use: position statement of the Joint Task Force for the American Academy of Allergy, Asthma and Immunology and the American College of Allergy, Asthma and ImmunologyLeonard Bielory, Michael Blaiss, Stanley M Fineman, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 10, 2019
Guiding Principles for the Recognition, Diagnosis, and Management of Infants with Anaphylaxis: An Expert Panel ConsensusMatthew Greenhawt, Ruchi S Gupta, J Allen Meadows, et al.
The Journal of Allergy and Clinical Immunology|November 10, 2009
Recent asthma exacerbations predict future exacerbations in children with severe or difficult-to-treat asthmaTmirah Haselkorn, Robert S Zeiger, Bradley E Chipps, et al.
The New England Journal of Medicine|January 4, 2008
Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxisPeter Vadas, Milton Gold, Boris Perelman, et al.
Plos One|October 17, 2012
Elevated antigen-driven IL-9 responses are prominent in peanut allergic humansJungang Xie, Larisa C Lotoski, Rishma Chooniedass, et al.
Pageof 16